Loss of function mutations in Methyl-CpGbinding Protein 2 (MeCP2) cause the severe neurological disorder Rett Syndrome. MeCP2 is a highly abundant nuclear protein particularly enriched in neurons. Although biochemical and genomic analyses of MeCP2-DNA interaction and genomic distribution demonstrate that MeCP2 binding on chromatin is dependent on DNA modification state, the dynamic behavior of individual MeCP2 proteins in live neurons has not been explored. Here we use live-cell singlemolecule imaging to assess the detailed kinetic features of MeCP2 in distinct sub-nuclear regions at high spatial and temporal resolution. Surprisingly, we found that, in granule cell nuclei, MeCP2 has unique diffusion and chromatin binding kinetics that are distinct from highly mobile sequence-specific transcription factors (TF) and immobile histone proteins. Approximately, half of MeCP2 is bound to DNA in a transiently stable mode that is similar to TF binding to their cognate sites. The binding of meCP2 to DNA requires its methyl-binding domain (MBD) and is sensitive to the levels of both DNA methylation and hydroxymethylation. However, when not stably bound, MeCP2 moves slowly in the nucleus most closely resembling histone H1.0. The rate of MeCP2 diffusion in compact, granule cell nuclei is determined by weak, transient DNA interactions mediated primarily by the MBD and three AT-hook domains located in the C-terminal portion of the protein. Both the fraction of stably bound MeCP2 and its rate of diffusion depend on the level of chromatin compaction and neuronal cell type.
Summary
Loss of function mutations in Methyl-CpGbinding Protein 2 (MeCP2) cause the severe neurological disorder Rett Syndrome. MeCP2 is a highly abundant nuclear protein particularly enriched in neurons. Although biochemical and genomic analyses of MeCP2-DNA interaction and genomic distribution demonstrate that MeCP2 binding on chromatin is dependent on DNA modification state, the dynamic behavior of individual MeCP2 proteins in live neurons has not been explored. Here we use live-cell singlemolecule imaging to assess the detailed kinetic features of MeCP2 in distinct sub-nuclear regions at high spatial and temporal resolution. Surprisingly, we found that, in granule cell nuclei, MeCP2 has unique diffusion and chromatin binding kinetics that are distinct from highly mobile sequence-specific transcription factors (TF) and immobile histone proteins. Approximately, half of MeCP2 is bound to DNA in a transiently stable mode that is similar to TF binding to their cognate sites. The binding of meCP2 to DNA requires its methyl-binding domain (MBD) and is sensitive to the levels of both DNA methylation and hydroxymethylation. However, when not stably bound, MeCP2 moves slowly in the nucleus most closely resembling histone H1.0. The rate of MeCP2 diffusion in compact, granule cell nuclei is determined by weak, transient DNA interactions mediated primarily by the MBD and three AT-hook domains located in the C-terminal portion of the protein. Both the fraction of stably bound MeCP2 and its rate of diffusion depend on the level of chromatin compaction and neuronal cell type.
Introduction
Methyl-CpG-binding protein 2 (MeCP2) is an abundant nuclear protein that was initially identified as the founding member of the methyl-DNA binding proteins family . Mutations in the X-linked MeCP2 gene cause Rett syndrome, a severe neurological disorder characterized by developmental regression during the first few years of life (Amir et al., 1999) . Although MeCP2 is expressed by all cell types, it is present at very high levels in neurons (Skene et al., 2010) . Loss of MeCP2 is not lethal to these cells but results in alterations in gene expression and reduced cellular growth (Armstrong et al., 1995; Chahrour et al., 2008) . Although the consequences of MeCP2 loss are well documented, the mechanisms by which MeCP2 functions may include both the recruitment of specific epigenetic regulatory factors to select sites in the genome (Chahrour et al., 2008; Jones et al., 1998; Kokura et al., 2001; Kruusvee et al., 2017; Lyst et al., 2013) and a more general role as an organizer of chromatin topology in broad nuclear regions (Baker et al., 2013; Della Ragione et al., 2016; Linhoff et al., 2015; Lyst and Bird, 2015) . Given the abundance of MeCP2 and its important role in the regulation of chromatin structure and gene expression, further investigation of its chromatin interactions in neurons is of interest.
Genome-wide mapping studies of MeCP2 have shown that it is enriched in highly methylated regions, although it can be found also in regions where levels of DNA methylation are low (Baubec et al., 2013; Mellen et al., 2017; Skene et al., 2010) . Oddly, despite its high expression in neurons, MeCP2 is not sufficiently abundant to bind simultaneously to all methylated sites in the neuronal genome. This suggests that the global distribution of MeCP2 observed in ChIP studies might result from summation of MeCP2-chromatin interactions that are rather sparse with respect to DNA methylation and quite dynamic. This is consistent with previous imaging studies that have employed fluorescence recovery after photobleaching (FRAP) to document the mobility of MeCP2 in the nucleus of culture cell lines (Agarwal et al., 2011; Ghosh et al., 2010a; Kumar et al., 2008) . While these indirect measurements of average MeCP2 behavior over large regions of the nucleus indicate that MeCP2 is mobile, they provide little insight into the mechanisms governing MeCP2 target site selection.
Recent single molecule imaging studies of transcription factors in living cells have yielded surprising insights into their dynamic behavior in the nucleus, and revealed unanticipated features of their target search strategies that ought to be considered in models of eukaryotic gene regulation (Chen et al., 2014b; Chong et al., 2018; Liu and Tjian, 2018) . To gain additional insights into the dynamic behavior of MeCP2 and its interactions with neuronal chromatin, we have applied this approach to the analysis of MeCP2 in the nucleus of living neurons. Measurements of the behavior of single MeCP2 molecules in the nucleus of cerebellar granule cells relative to other well-studied nuclear proteins revealed that the binding and diffusion of MeCP2 in neurons is similar to H1 linker histones, and distinct from both core histones and site-specific transcription factors. Specifically, extensive mutagenesis experiments demonstrate that MeCP2 behavior in the nucleus can be functionally attributed to a stably bound state with short life times (~7 sec) and an unbound state with MeCP2 diffusing much slower than site-specific TFs. Interestingly, we found that the fraction of stably bound state is exquisitely sensitive to the level of DNA modification, and is altered by Rett Syndrome mutations that impact the methyl-CpG binding domain (MBD).
In contrast, independent interactions governed by the three AT hook domains at the C-terminus of MeCP2 played a dominant role in regulating the diffusion of unbound MeCP2 with relatively minor contributions from MBD. Furthermore, MeCP2 mobility in the nucleus is sensitive to the local chromatin environment in granule cells, and is dramatically accelerated in the large, euchromatic nuclei of Purkinje cells. Together, our results provide a physical model to explain how distinct types of molecular interactions regulate dynamic MeCP2 binding and diffusion behavior in the nucleus that likely impact its function.
Results
MeCP2 nuclear dynamics at single molecule resolution in cerebellar neurons reveals its unique slow diffusive behavior. To study MeCP2 at single molecule resolution in live neurons, we transfected mouse cerebellar granule cells with a construct expressing MeCP2-HaloTag fusion protein and cultured them for 12-14 days to generate a monolayer of neuronal cells that is ideal for image acquisition (Figure 1A) . To measure the behavior of MeCP2 relative to other well studied nuclear proteins, in parallel we used vectors expressing the HaloTag domain fused to the histone H2b, a small domain containing MeCP2 minimal nuclear localization signal (NLS), the transcription factors Sox2 and TBP, and the linker histone H1.0. The cells were then incubated with the fluorescent HaloLigand JF549 to specifically label HaloTagged proteins (Figure 1B) .
Images from sparsely labeled living granule cells (Figure1C) were acquired at 100 Hz to generate 2D single molecule tracks of the movements of each protein in the nucleus. It is evident from these single molecule trajectories (Figure 1D ) that the dynamics of MeCP2 in granule cell nuclei is quite distinct from stably bound histone (H2b) or sequence specific transcription factors (Sox2 and TBP), while it seems to mirror H1.0 behavior. Likewise, the distribution of diffusion coefficients calculated for individual MeCP2 molecules recapitulates that for the linker histone H1.0, but differs from those for other control proteins ( Figure 1E ). Although these data reveal that MeCP2 molecules, similar to transcription factors, are present as both stably bound and mobile species, strikingly mobile MeCP2 molecules diffuse much slower than Sox2 or TBP molecules.
To better evaluate the distinctive diffusive properties of MeCP2 molecules, we used the algorithm package Spot-On . Assuming that nuclear proteins can be found in two alternative states (bound and unbound), Spot-On derives the fraction of bound molecules (diffusing <0.08 µm 2 /s) and the diffusion coefficient of those that are unbound ( Figure 1F ). As expected given their stable incorporation into nucleosomes, the vast majority of H2b molecules (>80%) are immobile, while most of the NLS molecules (80-90%) are very rapidly diffusing (~4 µm 2 /s). As previously shown, a minority of Sox2 and TBP molecules are stably bound. Diffusion of unbound Sox2 and TBP proteins is relatively rapid, and similar to that previously reported for ES cells, averaging ~2 and 1.5 µm 2 /s per cell respectively, ( Figure 1F ) (Chen et al., 2014b) . These data confirm the general rule for sequence-specific transcription factors that less than half of the population is stably bound to DNA, and the rest moves rapidly 'searching' chromatin to find cognate binding sites. Two features distinguish the dynamic behavior of MeCP2 from transcription factors ( Figure 1F) . First, the fraction of MeCP2 molecules bound in a stable mode is significantly higher than that of Sox2 or TBP. Thus, approximately half of the MeCP2 population is stably bound in granule cell nuclei at any given time. Second, when not bound stably, MeCP2 diffuses significantly slower (averaging ~1 µm 2 /s per cell) than Sox2, TBP or the NLS control. Interestingly, the dynamic behavior of MeCP2 is strikingly similar to the linker histone H1.0, where ~50% of molecules are immobile and the rest diffuse slowly inside the nucleus ( Figure 1F ).
In order to determine the residence time of the stably bound proteins on chromatin, we imaged the sparsely labeled nuclei at low excitation power and long acquisition time (500ms/frame). As a result, while mobile particles are blurred into the background, immobile single molecules are selectively recorded as individual bright spots that can be tracked until they dissociate from their binding sites or become photo-bleached by the laser illumination ( Figure S1A ). As previously shown (Chen et al., 2014b) , the dissociation kinetics of nuclear factors interacting with chromatin can be described by a double exponential decay that accounts for short-lived and long-lived populations of molecules (Figure S1B) . This dwell time analysis shows that only a quarter (~25%) of the immobile MeCP2 molecules are long-lived, a level comparable with control constructs. Short-lived molecules have similar residence time for all nuclear factors (>2 seconds), while the residence time of long-lived molecules varies from protein to protein ( Figure  S1C ). Long-lived MeCP2 molecules display a residence time of ~7 seconds, which is significantly shorter than for transcription factors Sox2 and TBP (~10 and ~14 seconds, respectively) or the linker histone H1.0 (~10 seconds), but yet longer than control NLS (~5 seconds) (Figure S1C ). This suggests that MeCP2 engages in specific interactions with cognate DNA sites that are transient and highly dynamic.
MeCP2 nuclear dynamics is independent from its expression level.
MeCP2 gene dosage is critical for normal neuronal function (Collins et al., 2004; Ramocki et al., 2009) . To establish that the slow diffusive properties we have measured reflect the properties of endogenous MeCP2, we generated a mouse line genetically engineered to harbor an in-frame sequence encoding the HaloTag domain in the 3' UTR of Mecp2 gene (Figure S2A and B) . Animals expressing the MeCP2-HaloTag fusion protein are viable and show no disease phenotype, demonstrating that the HaloTag domain does not disrupt MeCP2 physiological function. Single molecule tracks of endogenous MeCP2 imaged in granule cells cultured from the knock-in mice resemble those generated by exogenously expressed proteins ( Figure 1D) . Furthermore, the distributions of diffusion coefficients for individual molecules of exogenous and endogenous MeCP2 strongly overlap ( Figure 1E ). Both the bound fraction and the rate of diffusion of the unbound molecules calculated for single cells do not differ significantly between the two conditions ( Figure  1F ), indicating that endogenous and exogenous MeCP2 have identical nuclear dynamics in granule cells.
As an additional control to directly demonstrate identical dynamic properties of endogenous and exogenously introduced MeCP2, we co-cultured MeCP2-HaloTag granule cells transfected with a vector expressing a MeCP2-GFP fusion protein with untransfected MeCP2-HaloTag granule cells (Figure S3A) . In this way, MeCP2 molecules could be acquired from cells expressing them at endogenous level (GFP negative) and, in parallel from cells containing additional copies of exogenously expressed MeCP2 proteins (GFP positive, Figure S3B ). No difference between these two conditions could be detected in the distribution of MeCP2 diffusion coefficients (Figure S3C) , the fraction of bound molecules or diffusion rate of unbound molecules per cell ( Figure S3D ). Furthermore, the dwell time analysis revealed comparable behavior for MeCP2 regardless of the expression system ( Figure S3E ). Taken together, our data demonstrate that the dynamic behavior of MeCP2 in granule cell nuclei is distinct from both stably bound histones and typical sequence-specific transcription factors. It is also established that both the endogenously and exogenously expressed MECP2-HaloTag proteins are suitable for in depth investigation of both its bound state, and the factors contributing to the peculiar, slow diffusion of unbound MeCP2 in neuronal nuclei.
MeCP2 Chromatin binding is sensitive to DNA modification levels in neurons.
Biochemical studies have initially determined that the ability of MeCP2 to bind DNA depends on the presence of methylated cytosines (5mC) ) and more recently, it was shown that hydroxylation of these sites (5hmC), when it occurs in the context of CpG, disrupts this interaction ( Figure 4SA ) (Gabel et al., 2015; Mellen et al., 2017) . Once neurons become postmitotic, they begin accumulating de novo DNA methylation sites by the activity of DNA methyltransferase 3a (DNMT3a), as well as converting 5mC to 5-hyroxymethylcytosine (5hmC) through the enzymes Tet1, 2 and 3 (Lister et al., 2013; Stroud et al., 2017) . To understand the relationship between these DNA modifications and MeCP2 dynamics in live granule cells, we removed these epigenetic factors using appropriate conditional alleles and Cre drivers, and we observed MeCP2 behavior by expressing Double-floxed Inverted Orientation (DIO) MeCP2-HaloTag (Figure 2A) .
We employed the Neurod1 Cre driver line in Dnmt3a flox/flox animals to generate granule cells lacking de novo DNA methylation (Neurod1Cre;Dnmt3a flox/flox , Dnmt3a_cKO, Figure  2A ), which resulted in ~20% decrease of total 5mC level in both CG and non-CG sequence contexts (Figure S4B, C, D and E) . MeCP2 nuclear trajectories recorded in these hypomethylated granule cells display increased mobilty as shown by cumulative distribution of D' values for individual molecules ( Figure S4G ). The fraction of bound MeCP2 in the Dnmt3a KO cells decreased from ~55% to ~45%, in good agreement with the ~20% depletion of DNA methylation in these cells (decrease from ~6 to 5% of all cytosines, Figure S4C ). In contrast, the rate of diffusion of unbound MeCP2 molecules is largely unaffected by this decrease in DNA methylation (Figure 2B) .
To prevent DNA oxidation of 5mC to 5hmC in granule neurons, we depleted the three al., 2016) (Figure 2A ). Because a DIO-MeCP2-HaloTag construct was co-transfected in these cells, MeCP2-HaloTag could only be observed in cells impaired of Tet activity (Tets_cKO) and in turn devoid of 5hmC sites ( Figure S4F ). Loss of expression of Tet proteins results in a subtle reduction in MeCP2 nuclear mobility as observed by the distribution of diffusion coefficients for individual molecules (Figure S4G) . While the diffusion of unbound MeCP2 molecules remains essentially unchanged in these cells lacking 5hmC, the fraction of bound molecules increases from ~55% to ~60%, (Figure 2B) . This is consistent with the higher number of high affinity 5mCG binding sites expected as a result of the failure to convert them to low affinity 5hmCG sites. We note that the small magnitude of this change is not surprising since less than 0.5% of all cytosines are hydroxylated in the granule cell genome ( Figure S4BC ).
Taken together, these data suggest that MeCP2 behavior in live neurons is tightly regulated by epigenetic modifications of the DNA. Thus, as predicted from previous biochemical studies ( Lewis et al., 1992; Mellen et al., 2017 ), a decrease in the level of DNA methylation as a result of Dnmt3a deletion causes a reduction in the fraction of stably bound MeCP2 in vivo. Conversely an increase in DNA methylation as a consequence of deletion of the Tet oxidases results in an increase in the fraction of stably bound MeCP2. The slow rate of diffusion of unbound MeCP2 in vivo is not dependent on DNA methylation and, therefore, must reflect other distinct biochemical properties of MeCP2.
MeCP2 MBD is required for stable binding and constrains its diffusion in granule cell nuclei.
To investigate further the contribution of DNA binding to MeCP2 dynamic behavior, we targeted the MBD domain with two common Rett syndrome mutations, known to disrupt MeCP2 DNA binding to different degrees (Cuddapah et al., 2014) : R106W, which completely abolishes DNA binding and R133C which retains significant DNA binding capacity (Nikitina et al., 2007) . R106W-HaloTag DIO and R133C-HaloTag DIO were expressed in cultured NeruoD1Cre+ granule cells in parallel with wild type MeCP2 ( Figure 3A ). As expected, given their distinct DNA binding properties, the two MeCP2 mutants display different behaviors in the nucleus of cultured granule cells. The nuclear distribution of R106W appears very homogenous in the nucleus of granule cells, and its nuclear trajectories differ dramatically from wild type. In contrast, the distribution of R133C in the nucleus and its single molecule tracks resemble wild type MeCP2 ( Figure 3B ).
Quantitative analyses of the behavior of single molecules for each of these forms of MeCP2 confirm these observations (Figure 3 B, C, D) . The distribution of diffusion coefficients calculated for individual molecules shows that both mutations result in increased MeCP2 mobility, but to different extents. In particular, SpotOn analysis of R106W molecules demonstrates that the loss of DNA binding capacity in this mutant strongly decreases the fraction of stably bound protein, and results in a significant increase in its rate of diffusion in the nucleus (from ~1 µm 2 /s to ~1.4 µm 2 /s). The behavior of the R133C mutation is quite different. As anticipated from its nuclear distribution and the appearance of its single molecule nuclear trajectories, the fraction of stably bound R133C does not differ significantly from wild type MeCP2. Interestingly, however, the rate of diffusion of the unbound R133C protein is measurably increased (from ~1 µm 2 /s to ~1.2 µm 2 /s). These experiments confirm the expectation that stable binding of MeCP2 in living nuclei requires the MBD, and indicate that this domain can also constrain the mobility of unbound MeCP2 as it samples potential sites for stable binding. unbound conventional transcription factors prompted us to investigate which domains of MeCP2 contribute to this interesting behavior. The MBD is encoded by less than 25% of the MeCP2 sequence and structural studies have revealed that most of the protein is composed of Intrinsically Disordered Domains (IDDs) ( Figure  4A ). Rett syndrome nonsense mutations involve many domains outside of the MBD (Figure 4A ) (Krishnaraj et al., 2017) , in agreement with previous studies establishing the importance of several of these in MeCP2 interaction with chromatin and function (Ghosh et al., 2010b; Lyst and Bird, 2015) . In addition to three small ATHook domains, MeCP2 IDDs comprise the Nterminal sequence (N-term), an Intervening domain (ID) which connects MBD to the Transcriptional Repressive Domain (TRD), containing nuclear localization signal (NLS) and the NCoR interaction domain (NID), and a Cterminal domain (C-term). To examine the impact of these domains on MeCP2 dynamics in living neuronal nuclei, we transfected Neurod1Cre+ cerebellar granule cells with DIO constructs expressing the HaloTag in frame with several IDD depleted versions of MeCP2 protein in parallel with full-length wild type MeCP2 as a control ( Figure 4B ). Cultured granule cells expressing these constructs were imaged in the same experimental conditions described above to generate single molecule trajectories, which were then analyzed to measure the fraction of stably bound molecules and the diffusion rate of unbound molecules ( Figure 4C ).
Minimal MeCP2 proteins containing only the MBD and NLS maintain the level of DNA binding relative to wild type control, but when unbound, diffuse significantly faster (~1.5μm 2 /s) than fulllength MeCP2 (~1μm 2 /s). This confirms that MBD is sufficient for stable DNA binding in vivo, and indicates that additional IDDs are involved in weak interactions that limit MeCP2 nuclear diffusion but largely do not contribute to stable binding. Introduction of the inactivating R106W mutation into the MBD of this minimal construct reduces stable binding to background levels, and increases further the diffusion of unbound molecules (~2μm 2 /s). When taken together with the effects of the R106W and R133C MBD mutations on full length MeCP2, these data demonstrate that the MBD is necessary and sufficient for stable DNA binding in granule cells; that it partially constrains diffusion of unbound MeCP2; and that additional domains of the protein must also contribute to the diffusive properties of MeCP2.
To identify additional domains of MeCP2 that determine its slow diffusion in living granule cell nuclei, we progressively added individual IDDs back to the minimal R106W protein and measured their effects on MeCP2 nuclear diffusion. The addition of the N-terminal domain (+N-term) does not change the dynamic behavior of the protein. Inclusion of the ID domain (+ID), which contains an AT-hook domain, significantly reduces diffusion of unbound molecules. The incorporation of a five amino acid sequence (RGRKP) at residue 268 reconstitutes a second AT-hook domain (+AT-Hook2) but does not affect MeCP2 diffusion rate. However, if AT-hook2 is assayed independently by in-frame fusion to the rapidly diffusing NLS-HaloTag molecules, it is capable of slowing diffusion in granule cell nuclei. (Figure S5A , B and C). The inclusion of the NID domain further constrains MeCP2 nuclear mobility to a diffusion rate comparable to full length R106W proteins (~1.4μm 2 /s). Restoration of the full-length protein with the addition Cterminal domain, including a third AT-hook, does not affect MeCP2 diffusion ( Figure 4C ). Finally, since there is a great deal of evidence that MeCP2 AT-hook domains play a significant role in its function (Baker et al., 2013; Sheikh et al., 2018) , we tested whether these alone were sufficient to determine the slow diffusion rate of unbound MeCP2. Surprisingly, the full length R106W protein lacking all three AT-hooks displays identical dynamic behavior to the minimal R106W protein that solely contains a nonfunctional MBD (Figure 4C and D) .
Taken together, these results demonstrate that the IDDs of MeCP2 are not required for stable DNA binding in the nucleus of granule cell neurons. Rather, we find that they engage in weak, transient interactions with genomic DNA or chromatin. In particular, our data highlight the MeCP2 AT-hook domains as very important players in the constraint of MeCP2 diffusion in the nucleus.
MeCP2 nuclear dynamics is sensitive to the level of chromatin compaction.
The structure function studies we have presented demonstrate that the dynamic behavior of MeCP2 in the nuclei of living granule cells resembles the linker histone H1.0, that it is sensitive to DNA modifications, and that it depends on both its MBD and the IDDs. The MBD is sufficient for stable binding of MeCP2 in the nucleus, and independently contributes to its slow diffusion when unbound. By contrast, the AT-hook domains of MeCP2 provide major constraints to the mobility of unbound MeCP2 in granule cells, without generating significant stable binding. Since these domains are known to mediate nonspecific interactions that occur in the minor groove of AT-rich DNA independently from DNA methylation, and MBD engages in specific binding to methylated cytosines, the behavior of MeCP2 is most likely the result of a combination of specific and non-specific interactions. Given the increased DNA concentration and the enrichment of methylated DNA in highly compact heterochromatin, we next tested the diffusive properties of MeCP2 in euchromatic and heterochromatic domains of the granule cell nucleus.
To identify compact chromatin domains in living nuclei, we transfected a fusion of Heterochromatin Protein 1 alpha in frame with the Blue Fluorescent Protein (HP1α-BFP) in MeCP2-HaloTag granule cells. In this way, it is possible to identify regions in the nucleus of living neurons that are highly compact (heterochromatin, HP1α positive) or more loosely arranged (euchromatin, HP1α negative) ( Figure 5A ). From snapshot acquisitions of HP1α-BFP signal we generated filtering masks, which allowed us to discriminate single molecule tracks recorded within heterochromatin (inside the mask, red) and those occurring within euchromatin (outside the mask, green) ( Figure  5B ). Although the differences in the two nuclear sub-regions are not large enough to be assessed at the population level (Figure 5E ), the distributions of the diffusion coefficients of individual molecules show that euchromatic MeCP2 molecules tend to be slightly more dynamic than in heterochromatin (Figure 5C and 5D) . Furthermore, dwell time analysis shows that while MeCP2 residence times remain unchanged, the fraction of long-lived bound molecules is significantly higher in heterochromatin than euchromatin, consistent with the elevated number of MeCP2 binding sites ( Figure 5F ).
MeCP2 mobility depends on the cell type and nuclear architecture.
Despite the very compact nature of granule cell nuclei, we observed subtle differences in MeCP2 dynamic behavior that correlate with the level of chromatin compaction. To further probe this observation, and to determine whether the properties of MeCP2 change in cell types whose nuclear architecture varies significantly from granule cells, we chose to compare its behavior in granule cells and Purkinje cells (Figure 6A, S2B) . We prepared acute slices from the cerebellum of the MeCP2-HaloTag animals, incubated them with the JF549 ligand, and imaged MeCP2 single molecule trajectories in granule cells and Purkinje cells using lattice light sheet microscopy (Chen et al., 2014a) .
The dynamic features of MeCP2 in granule cells from acute cerebellar slices are remarkably similar to culture experiments. Although the fraction of stably bound MeCP2 is slightly higher in the acute slices prepared from adult mice compared to cultured granule cells, the slow diffusion of unbound MeCP2 is indistinguishable in the two conditions (Figure 6, S6A) . The dynamic behavior of MeCP2 in the large, euchromatic nuclei of Purkinje cells is very different. As is evident from the distinct appearance of single molecule tracks in Purkinje cells (Figure 6A ), the cumulative distribution of the diffusion coefficients for individual molecules in Purkinje cells demonstrates that MeCP2 is significantly more mobile in the large, euchromatic Purkinje cell nuclei ( Figure 6B ). Furthermore, while the fraction of stably bound MeCP2 molecules is similar between these cell types (70 vs. 60%), unbound MeCP2 diffuses considerably faster (~2X) in PC than it does in GC ( Figure 6C ). Finally, the dwell time analysis shows a higher fraction of long-lived immobile molecules in GC compared to PC ( Figure S6B ). We conclude that nuclear architecture and chromatin compaction play major roles in the dynamic behavior of MeCP2, and that differences in these properties between cell types may influence MeCP2 function in yet unexplored ways.
Discussion
Recent single molecule imaging studies have provided important insights into transcription factor activity that complement those obtained from biochemical, genomic and ensemble imaging studies (Chen et al., 2014b; Liu and Tjian, 2018 ). Here we have adopted this approach to measure the dynamic behavior of the fundamentally important neuronal methyl-CpG binding protein (MeCP2) in live neurons. The data we have collected both confirm previous studies of the structure and function of MeCP2, and reveal interesting new features that are important to consider in models of its roles in neuronal nuclei.
The dynamic behavior of MeCP2 in granule cells resembles histone H1.0 but is highly sensitive to the level of DNA methylation. Previous studies using FRAP have reported that in cultured cell lines the overall mobility of MeCP2 and histone H1.0 are similar (Ghosh et al., 2010a) . Our measurements from single molecule imaging experiments of both endogenous and exogenously expressed MeCP2 in primary cultures of cerebellar granule neurons, as well as in acute slice preparations from adult mouse cerebellum, confirm and extend these observations. The analysis of individual nuclear trajectories demonstrates that both H1.0 and MeCP2 are less stable than the core histone H2b, but are not as mobile as sequence specific transcription factors Sox2 and TBP. Although similarly to Sox2 and TBP, only a fraction of MeCP2 and H1.0 is immobile in neuronal nuclei, the rates of diffusion of the unbound molecules are much slower than these transcription factors, indicating that MeCP2 and H1.0 are somehow more productively and continuously engaging in interactions with chromatin (Figure 1) . Despite the similar, constrained diffusion of MeCP2 and histone H1.0, a larger fraction of MeCP2 is engaged in long-term stable binding events than H1.0, although residence time when stably bound is significantly shorter (Figure S1 ).
In contrast to linker histones, MeCP2 binding is strongly regulated by DNA methylation. While it can interact non-specifically with DNA with low affinity, MeCP2 high affinity interactions depend on the presence of 5mC sites (Baubec et al., 2013; Meehan et al., 1992) , which are masked by conversion to 5hmC (Mellen et al., 2017) . ChIP assays from fixed neuronal tissue and native genome wide mapping studies have shown that MeCP2 genome occupancy in neurons is cell type specific and correlated with the status of cytosine modification (Mellen et al., 2017) . The live cell imaging data we present here confirm these results, and reveal that the behavior of single MeCP2 molecules in neuronal nuclei respond quantitatively to alterations in DNA modification. Thus, without affecting the diffusion of unbound molecules, the balance of Dnmt3a and Tet activities tightly modulates the amount of available high affinity binding sites and dictates the magnitude of stably bound MeCP2 molecules in each cell (Figure 2) .
The fact that the fraction of MeCP2 bound stably in live neurons is very sensitive to alterations in high affinity 5mC binding sites despite their large excess (~10X) in the genome relative to the number of MeCP2 molecules, indicates that MeCP2 dynamic behavior is determined by the probability of encountering these targets relative to low affinity sites rather than by the absolute levels of DNA methylation. This suggests that epigenetic modifications accumulating on the DNA of postmitotic neurons determine the local enrichment, and presumably function, of MeCP2 in neuronal nuclei.
Different aspects of MeCP2 dynamic behavior are governed by distinct protein domains.
Several functional domains have been identified previously in MeCP2 and shown to play important roles in vivo and in vitro (Baker et al., 2013; Ghosh et al., 2010b; Heckman et al., 2014; Tillotson et al., 2017 (Ballestar et al., 2000; Yusufzai and Wolffe, 2000) . The R106W mutation, which has been reported previously to eliminate high affinity binding of MBD (Ballestar et al., 2000) and to result in a very severe clinical outcome (Cuddapah et al., 2014) , dramatically decreases the binding of MeCP2 in live neurons whether in the context of the intact protein or a minimal MBD isoform (Figure 3 and 4) . Interestingly, this single point mutation also increases the diffusion of unbound MeCP2, indicating that the MBD also constrains movement of MeCP2 in the nucleoplasm. Mutation R133C causes a mild form of Rett Syndrome (Cuddapah et al., 2014) , and has a rather attenuated phenotype when knocked in to the mouse genome (Brown et al., 2016) . In our single molecule studies in live neurons, this mutation has no discernable effect on the fraction of MeCP2 bound stably to DNA. Rather, R133C alters the rate of diffusion of MeCP2 when not stably bound in vivo. This agrees with prior studies indicating that R133C does not disrupt high affinity binding to methylated DNA (Brown et al., 2016) , and provides additional support for a role of the MBD in constraining the movement of unbound MeCP2 suggesting that alterations in the dynamic behavior of MeCP2 when not stably bound to DNA may also have important functional consequences in its mode of diffusion. The MeCP2 Intrinsically Disordered Domains. Numerous studies have shown that MeCP2 requires both an intact MBD and its C-terminal intrinsically disordered domains (IDDs) to execute its function (Lyst and Bird, 2015) . Here we show that MeCP2 lacking IDDs maintains its DNA binding properties, but diffuses faster, indicating that the MBD is sufficient to bind high affinity target sites while IDDs likely engage in low affinity interactions, possibly with DNA as well as other proteins in the nucleus. To assess which of these additional domains of MeCP2 are important for determining its dynamic properties in granule cell nuclei, we have assayed their independent contributions in the context of the R106W MBD mutation that eliminates stable DNA binding. The inclusions of the Intervening Domain (ID) and the NCoR/SMRT Interaction (NID) are sufficient to restore the slow rate of diffusion of the full-length protein (Figure 4) , corroborating previous studies showing that ID binds non-specifically to DNA at low affinity (Claveria-Gimeno et al., 2017; Ghosh et al., 2010b) and that the NID domain is an important hub for the recruitment of epigenetic factors (Lyst et al., 2013) . The MeCP2 AT-Hook Domains. In the C-terminal portion of its amino acid sequence, MeCP2 contains three small AT-hook DNA binding domains within and surrounding the ID and NID ( Figure 4A ). Earlier investigations of these domains have demonstrated that they are involved with MeCP2 function (Baker et al., 2013) and, similar to other AT-hook domains, interact preferentially with AT rich DNA (Reeves and Nissen, 1990) . Here we have shown that these low affinity interactions alone can determine the slow diffusion of MeCP2 in granule cells. Thus, lack of AT-hooks eliminates ID and NID contributions to MeCP2 dynamic behavior, indicating that ID requires AT-hook 1 to bind DNA and that NID requires at least two AT-hook domains to assemble protein complexes independently from MBD (Figure 4) . This demonstrates that the AT-hook domains are critically important determinants influencing the dynamic behavior of MeCP2 in living neurons, and they strongly support the hypothesis that they play an important role in MeCP2 function (Baker et al., 2013) .
MeCP2 dynamic behavior is sensitive to local chromatin structure. The dynamic behavior of MeCP2 in granule cell nuclei results from both high affinity specific interactions with methylated DNA and nonspecific low affinity interactions with chromatin. The probability of encountering these targets in the nucleoplasm determines MeCP2 behavior, and maximizes transient local interactions as MeCP2 samples DNA for its high affinity binding sites. Granule cell nuclei are among the most compact in the nervous system. Active regions of the granule cell genome are euchromatic, and they are interspersed with large regions of highly compact, inactive heterochromatin. Surprisingly, MeCP2 binding and mobility in euchromatin and heterochromatin is very similar. Although the average diffusion coefficient of MeCP2 molecules is lower in heterochromatin than in euchromatin (Figure 5C and D) , there is little apparent impact on the fraction of stably bound MeCP2, its rate of diffusion when unbound or residence times in these different chromatin domains (Figure 5E and F) .
In light of the very subtle differences we have observed in MeCP2 dynamics in granule cell heterochromatin and euchromatin, we were surprised at the dramatic differences in MeCP2 dynamic behavior we observed in the large, euchromatic nuclei of Purkinje cells. Although the decrease in the fraction of bound MeCP2 in Purkinje cells can be explained by the decrease in methylation and increase in hydroxymethylation of Purkinje cell DNA (Figure S7 ), the rapid diffusion of unbound MeCP2 in live Purkinje cell nuclei resembles that of conventional sequence specific transcription factors shown here and in other studies (Chen et al., 2014b) rather than the H1.0-like slow diffusion evident in granule cells. While the functional consequences of these differences in the dynamic behavior of MeCP2 in neurons with different nuclear architectures remain to be investigated, our data suggest that the consequences of specific MeCP2 mutations may vary substantially between cell types (Kron et al., 2012; Sugino et al., 2014) .
Concluding Remarks
Single molecule imaging studies of transcription factors in living nuclei have uncovered critical new features of their function that could not have been predicted based on biochemical or genomic approaches (Chen et al., 2014b; Chong et al., 2018; Hansen et al., 2018; Liu and Tjian, 2018; Loffreda et al., 2017; Teves et al., 2016) . Here we have presented a series of experiments that investigate in detail the molecular mechanisms that govern the dynamic behavior of MeCP2 in live neurons. Our results illustrate the complexity of MeCP2-chromatin interactions, which are sensitive to the level and state of cytosine methylation, depend on multiple protein domains, and differ depending on cell specific nuclear architecture. Although the dynamic behavior of MeCP2 resembles the linker histone H1.0, the specific features we have documented here allow MeCP2 function to be modulated locally as a result of changes in DNA methylation status and nuclear architecture. Given the variations evident in these determinants between cell type and in response to specific cues in a given neuronal lineage, our data support a dynamic role for MeCP2 in regulation of local chromatin structure. Figure S2 . The fraction of the molecules that display long-lived dwell time and the Resident Time (RT) of short and long-lived molecules were calculated for individual experiments and plotted as histograms displaying mean and standard deviation. Two-tailed unpaired t-test shows not significant changes between the two MeCP2 expression levels (ns, p>0.05). , μm 2 /s) calculated for individual molecules of full-length wild type MeCP2 (~20,000 molecules, red), Minimal (~10'000 molecules, orange), R106W full length (~20,000 molecules, dark blue), Minimal R106W (12,000 molecules, cyan), R106W-ΔAT-Hooks (~30,000 molecules, purple). 
